North America Heart Transplant Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Heart Transplant Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Heart Transplant Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Target Disease Incidence
5.1.2 Growing Geriatric Population

5.2 Market Opportunities

5.2.1 Improving Healthcare Capabilities and Growing Patient Pool in Emerging Nations

5.3 Future Trends

5.3.1 Growing adoption of AI in heart transplantation procedures are likely to act as future trends for the heart transplant market

5.4 Impact of Drivers and Restraints

6. North America Heart Transplant Market Regional Analysis

6.1 North America Heart Transplant Market Overview

6.2 North America Heart Transplant Market Revenue 2020-2030 (US$ Million)

6.3 North America Heart Transplant Market Forecast Analysis

7. North America Heart Transplant Market Analysis – by Surgery Type

7.1 Orthotopic Heart Transplant and Heterotopic Heart Transplant

7.1.1 Overview
7.1.2 Orthotopic Heart Transplant and Heterotopic Heart Transplant: North America Heart Transplant Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Heart Transplant Market Analysis – by Type

8.1 Donor Live Heart and Artificial Hearts

8.1.1 Overview
8.1.2 Donor Live Heart and Artificial Hearts: North America Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)

9. North America Heart Transplant Market Analysis – by End User

9.1 Hospitals

9.1.1 Overview
9.1.2 Donor Live Heart and Artificial Hearts: North America Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Cardiac Centers

9.2.1 Overview
9.2.2 Donor Live Heart and Artificial Hearts: North America Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)

10. North America Heart Transplant Market – North America Analysis

10.1 North America

10.1.1 North America Heart Transplant Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 North America Heart Transplant Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 US: North America Heart Transplant Market Breakdown, by Surgery Type
10.1.1.1.2 US: North America Heart Transplant Market Breakdown, by Type
10.1.1.1.3 US: North America Heart Transplant Market Breakdown, by End User

10.1.1.2 Canada: North America Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Canada: North America Heart Transplant Market Breakdown, by Surgery Type
10.1.1.2.2 Canada: North America Heart Transplant Market Breakdown, by Type
10.1.1.2.3 Canada: North America Heart Transplant Market Breakdown, by End User

10.1.1.3 Mexico : North America Heart Transplant Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Mexico : North America Heart Transplant Market Breakdown, by Surgery Type
10.1.1.3.2 Mexico : North America Heart Transplant Market Breakdown, by Type
10.1.1.3.3 Mexico : North America Heart Transplant Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Heart Transplant Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Terumo Corp

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Evaheart Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Abbott Laboratories

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 SynCardia Systems LLC

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 BiVACOR Inc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 BioVentrix Inc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Berlin Heart GmbH

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 LivaNova Plc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Jarvik Heart Inc

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights